FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Pediatric Trial Ethical Consideration Guide

FDA posts a draft guidance entitled Ethical Considerations for Clinical Investigations of Medical Products Involving Children.

latest-news-card-1
Medical Devices

QT Imaging Gets Clearance for Breast Scan Calculation

FDA grants QT Imaging a 510(k) clearance for its QTscan to calculate the fibroglandular volume of the breast and the ratio of that to total breast vol...

latest-news-card-1
Medical Devices

Philips Recalls Ventilators Over Contaminated Plastic

Philips Respironics recalls (Class 1) certain BiPAP (bi-level positive airway pressure) ventilators that may contain a plastic contaminated with a non...

latest-news-card-1
Human Drugs

Naloxone Guidance Attempts to Ease Availability

FDA releases an immediately-in-effect guidance entitled Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act (DSCSA...

latest-news-card-1
Federal Register

Info Collection on Abbreviated Animal Drug Apps

Federal Register notice: FDA sends to OMB an information collection extension for abbreviated new animal drug applications.

latest-news-card-1
Federal Register

Arthritis Advisory Committee Renewed for 2 Years

Federal Register notice: FDA renews its Arthritis Advisory Committee for an additional two years.

latest-news-card-1
Federal Register

Final Guide on 510(k) Template for eSubmission

Federal Register notice: FDA makes available a final guidance entitled Electronic Submission Template for Medical Device 510(k) Submissions.

latest-news-card-1
Human Drugs

Expand RTOR to Cell, Tissue Products: PhRMA

PhRMA says the FDA Oncology Center of Excellence Real-Time Oncology Review (RTOR) program should be expanded to include tissue and cell products regul...

latest-news-card-1
Human Drugs

Comments on Therapeutic Equivalence Draft Guidance

Five stakeholders comment on an FDA draft guidance on therapeutic equivalence evaluations.

latest-news-card-1
Marketing

OPDP to Study TV Ad Endorsers

The CDER Office of Prescription Drug Promotion says it wants to expand a current study on endorsers in print and Internet ads to cover TV spots.